Modeling the Effects of Subcutaneous Insulin Administration and Carbohydrate Consumption on Blood Glucose

Background: Estimation of the magnitude and duration of effects of carbohydrate (CHO) and subcutaneously administered insulin on blood glucose (BG) is required for improved BG regulation in people with type 1 diabetes mellitus (T1DM). The goal of this study was to quantify these effects in people with T1DM using a novel protocol. Methods: The protocol duration was 8 hours: A 1–3 U subcutaneous (SC) insulin bolus was administered and a 25-g CHO meal was consumed, with these inputs separated by 3–5 hours. The DexCom SEVEN® PLUS continuous glucose monitor was used to obtain SC glucose measurements every 5 minutes and YSI 2300 Stat Plus was used to obtain intravenous glucose measurements every 15 minutes. Results: The protocol was tested on 11 subjects at Sansum Diabetes Research Institute. The intersubject parameter coefficient of variation for the best identification method was 170%. The mean percentages of output variation explained by the bolus insulin and meal models were 68 and 69%, respectively, with root mean square error of 14 and 10 mg/dl, respectively. Relationships between the model parameters and clinical parameters were observed. Conclusion: Separation of insulin boluses and meals in time allowed unique identification of model parameters. The wide intersubject variation in parameters supports the notion that glucose-insulin models and thus insulin delivery algorithms for people with T1DM should be personalized. This experimental protocol could be used to refine estimates of the correction factor and the insulin-to-carbohydrate ratio used by people with T1DM.

[1]  Evanghelos Zafiriou,et al.  Robust process control , 1987 .

[2]  Howard Zisser,et al.  Practical issues in the identification of empirical models from simulated type 1 diabetes data. , 2007, Diabetes technology & therapeutics.

[3]  Malgorzata E. Wilinska,et al.  Insulin kinetics in type-1 diabetes: continuous and bolus delivery of rapid acting insulin , 2005, IEEE Transactions on Biomedical Engineering.

[4]  Eyal Dassau,et al.  Bolus calculator: a review of four "smart" insulin pumps. , 2008, Diabetes technology & therapeutics.

[5]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[6]  Thomas F. Edgar,et al.  Process Dynamics and Control , 1989 .

[7]  Jaques Reifman,et al.  Mathematical Modeling Research to Support the Development of Automated Insulin-Delivery Systems , 2009, Journal of diabetes science and technology.

[8]  Claudio Cobelli,et al.  Use of labeled oral minimal model to measure hepatic insulin sensitivity. , 2008, American journal of physiology. Endocrinology and metabolism.

[9]  D. Cox,et al.  Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. , 2004, Diabetes care.

[10]  A. Hisashige,et al.  Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study. , 2000, Diabetes research and clinical practice.

[11]  R. Hovorka,et al.  Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. , 2002, American journal of physiology. Endocrinology and metabolism.

[12]  C. C. Palerm,et al.  Effect of input excitation on the quality of empirical dynamic models for type 1 diabetes , 2009 .

[13]  Claudio Cobelli,et al.  A System Model of Oral Glucose Absorption: Validation on Gold Standard Data , 2006, IEEE Transactions on Biomedical Engineering.

[14]  Francis J. Doyle,et al.  Glucose control design using nonlinearity assessment techniques , 2005 .

[15]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[16]  L. Quinn,et al.  Estimation of future glucose concentrations with subject-specific recursive linear models. , 2009, Diabetes technology & therapeutics.

[17]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.

[18]  Robert S Parker,et al.  Dynamic modeling of free fatty acid, glucose, and insulin: an extended "minimal model". , 2006, Diabetes technology & therapeutics.

[19]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[20]  Roman Hovorka Management of diabetes using adaptive control , 2005 .